文献速递临床试验与 GCP流行病学与生物统计

减重饮食下乳清蛋白补充降低肥胖绝经前女性空腹内源性大麻素水平而不伴体重下降

Whey protein supplementation reducing fasting levels of anandamide and 2-AG without weight loss in pre-menopausal women with obesity on a weight-loss diet.
PubMed 文献 · Trials · 2020-07-17

该随机临床试验纳入60名肥胖绝经前女性,在低热量饮食基础上比较乳清蛋白粉(30克/天)与对照的效果。干预2个月后,干预组体重和BMI未见显著下降,但腰围、体脂、空腹血糖、AEA、2-AG、总胆固醇和甘油三酯降低,HDL-C显著升高。

要点

  • 乳清蛋白补充可降低肥胖女性空腹AEA和2-AG水平,独立于体重变化。
  • 干预组腰围、体脂、空腹血糖及血脂指标改善,HDL-C升高。
  • 体重和BMI在干预组与对照组间无显著差异。

核心结论

  • 在低热量饮食基础上补充乳清蛋白可降低肥胖绝经前女性空腹内源性大麻素水平,且不依赖体重下降。

研究设计与样本

  • 2个月随机临床试验,纳入60名肥胖女性,随机分为对照组(n=30)和干预组(n=30)。
  • 所有受试者接受低于估计能量需求800 kcal的低热量饮食,干预组额外补充乳清蛋白粉30 g/天。

主要发现

  • 干预组与对照组在能量和宏量营养素摄入上无显著差异(p > 0.05)。
  • 干预组体重和BMI相比对照组无显著降低(p > 0.05)。
  • 干预组腰围、体脂、空腹血糖、AEA、2-AG、总胆固醇和甘油三酯显著降低,HDL-C显著升高(p < 0.05)。

关键数值与推荐

  • 干预组乳清蛋白粉剂量为30 g/天,饮食为低于估计能量需求800 kcal的低热量饮食。
  • 基线时除MUFA摄入外(p = 0.021),两组特征均质(p > 0.05)。

临床怎么用

  • 对于肥胖绝经前女性,在减重饮食中补充乳清蛋白可能有助于改善内源性大麻素水平和代谢指标,即使体重未明显下降。

局限性

  • 研究期限仅2个月,样本量60例,长期效果未知。
  • 基线MUFA摄入在两组间存在差异(p = 0.021),可能影响结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite the importance of dairy proteins in modifying of metabolic abnormalities, no attention has been given to their effects on endocannabinoids. METHODS: A total number of 60 obese women were recruited in a 2-month randomized clinical trial. Following random allocation, they were assigned to one of the two groups: control (n = 30) and intervention (n = 30). Then, all the subjects followed a hypocaloric diet of 800 kcal below estimated energy needs. The intervention group received isocaloric weight-loss diet and whey protein powders (30 g/day). Baseline and 2-month fasting anthropometric, blood glucose, serum insulin, insulin resistance, lipid profile, AEA, and 2-AG were measured. RESULTS: The study groups were homogenous in terms of baseline characteristics (p > 0.05) except for MUFA intake (p = 0.021). There were no significant differences in energy and macronutrient intakes in the intervention group compared to the control group at the end of the study (p > 0.05). The results of the ANCOVA did not show significant reductions in body weight and BMI of the intervention group compared to the control group (p > 0.05); however, WC, body fat, FBS, AEA, 2-AG, total cholesterol, and triglyceride decreased and HDL-c significantly increased in the intervention group compared to the control group (p < 0.05). CONCLUSIONS: In this study, the effects of simultaneous weight-loss diet and whey protein supplementation on the reduction of endocannabinoids were determined. TRIAL REGISTRATION: Iranian Registry of Clinical Trials IRCT2017021410181N8 . Registered on March 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Haidari F, Aghamohammadi V, Mohammadshahi M, et al. Whey protein supplementation reducing fasting levels of anandamide and 2-AG without weight loss in pre-menopausal women with obesity on a weight-loss diet. Trials. 2020. PMID: 32680548. doi:10.1186/s13063-020-04586-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。